Loading clinical trials...
Loading clinical trials...
A Phase I/II Trial to Compare the Immunogenicity and Safety of 3 DNA C Prime Followed by 1 NYVAC C Boost to 2 DNA C Prime Followed by 2 NYVAC C Boost
Conditions
Interventions
DNA-C
NYVAC-C
Locations
2
France
Hôpital Henri Mondor
Créteil, France
Centre Hospitalier Universitaire Vaudois CHUV
Lausanne, Switzerland
Start Date
July 1, 2007
Primary Completion Date
December 1, 2008
Completion Date
October 1, 2009
Last Updated
November 26, 2009
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions